Dr. Ksenya Shliakhtsitsava
Claim this profileUT Southwestern/Simmons Cancer Center-Dallas
Studies Cancer
Studies Blood Cancers
4 reported clinical trials
16 drugs studied
Affiliated Hospitals
Clinical Trials Ksenya Shliakhtsitsava is currently running
Brentuximab Vedotin + Nivolumab
for Hodgkin's Lymphoma
This phase III trial compares the effect of adding immunotherapy (brentuximab vedotin and nivolumab) to standard treatment (chemotherapy with or without radiation) to the standard treatment alone in improving survival in patients with stage I and II classical Hodgkin lymphoma. Brentuximab vedotin is in a class of medications called antibody-drug conjugates. It is made of a monoclonal antibody called brentuximab that is linked to a cytotoxic agent called vedotin. Brentuximab attaches to CD30 positive lymphoma cells in a targeted way and delivers vedotin to kill them. A monoclonal antibody is a type of protein that can bind to certain targets in the body, such as molecules that cause the body to make an immune response (antigens). Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs such as doxorubicin hydrochloride, bleomycin sulfate, vinblastine sulfate, dacarbazine, and procarbazine hydrochloride work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Etoposide is in a class of medications known as podophyllotoxin derivatives. It blocks a certain enzyme needed for cell division and DNA repair and may kill cancer cells. Vincristine is in a class of medications called vinca alkaloids. It works by stopping cancer cells from growing and dividing and may kill them. Prednisone is in a class of medications called corticosteroids. It is used to reduce inflammation and lower the body's immune response to help lessen the side effects of chemotherapy drugs. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Adding immunotherapy to the standard treatment of chemotherapy with or without radiation may increase survival and/or fewer short-term or long-term side effects in patients with classical Hodgkin lymphoma compared to the standard treatment alone.
Recruiting2 awards Phase 3
Mobile Health and Social Media Intervention
for Cancer Survivors
This clinical trial tests the impact of a culturally-tailored home-based physical activity program on physical fitness in Hispanic or Latino/Latina adolescent and young adult (AYA) childhood cancer survivors. After treatment for cancer, some AYA survivors experience long-term effects from the cancer and its treatment including weight gain, fatigue and decreased physical fitness. Hispanic or Latino/Latina survivors may have a higher risk of these effects compared to non-Hispanics. Regular physical activity helps maintain healthy weight, energy levels and overall health. Participating in a culturally-tailored home-based physical activity program may help increase physical activity in Hispanic or Latino/Latina AYA childhood cancer survivors.
Recruiting1 award Phase 23 criteria
More about Ksenya Shliakhtsitsava
Clinical Trial Related1 year of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Ksenya Shliakhtsitsava has experience with
- Multi-component Mobile Health And Social Media Physical Activity Intervention
- Wearing A Physical Activity Tracker Alone
- Biospecimen Collection
- Neurological Assessments
- Clinical Evaluation
- Questionnaire Administration
Breakdown of trials Ksenya Shliakhtsitsava has run
Cancer
Blood Cancers
Down Syndrome
CHILD Syndrome
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ksenya Shliakhtsitsava specialize in?
Ksenya Shliakhtsitsava focuses on Cancer and Blood Cancers. In particular, much of their work with Cancer has involved treating patients, or patients who are undergoing treatment.
Is Ksenya Shliakhtsitsava currently recruiting for clinical trials?
Yes, Ksenya Shliakhtsitsava is currently recruiting for 2 clinical trials in Dallas Texas. If you're interested in participating, you should apply.
Are there any treatments that Ksenya Shliakhtsitsava has studied deeply?
Yes, Ksenya Shliakhtsitsava has studied treatments such as Multi-component mobile health and social media physical activity intervention, Wearing a physical activity tracker alone, Biospecimen Collection.
What is the best way to schedule an appointment with Ksenya Shliakhtsitsava?
Apply for one of the trials that Ksenya Shliakhtsitsava is conducting.
What is the office address of Ksenya Shliakhtsitsava?
The office of Ksenya Shliakhtsitsava is located at: UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas 75390 United States. This is the address for their practice at the UT Southwestern/Simmons Cancer Center-Dallas.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.